Yahoo! Finance: VICL NewsLatest Financial News for VICAL INCVical Announces News Release and Conference Call Schedule for Second Quarter 2008 Financial Results (PR Newswire)- July 29, 2008 Vical Incorporated today announced that the company will report financial results for the three months and six months ended June 30, 2008, before the opening of trading on Tuesday, August 5, and conduct a conference call and webcast to discuss the financial results and provide a company update at noon Eastern Time on Tuesday, August 5.http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/prnews/080729/latu505.... Vical Receives $1 Million Milestone Payment From AnGes MG for Angiogenesis Program (PR Newswire)- July 22, 2008 Vical Incorporated today announced the receipt of a $1.0 million cash payment from its partner, AnGes MG, Inc., reflecting continued progress of its Collategene angiogenesis program.http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/prnews/080722/latu507.... Vical Announces Breakthrough for Pandemic Influenza DNA Vaccines With Preliminary Human Data (PR Newswire)- July 17, 2008 Vical Incorporated today announced a breakthrough with preliminary clinical trial data demonstrating that DNA vaccines can safely achieve significant immune responses against H5N1 pandemic influenza in humans.http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/prnews/080717/lath018a... Vical to Present Phase 1 Data for Vaxfectin(R)-Formulated Pandemic Influenza DNA Vaccines (PR Newswire)- July 14, 2008 Vical Incorporated today announced the scheduled presentation of preliminary human safety and immunogenicity data from a Phase 1 trial of the company's Vaxfectin-formulated H5N1 pandemic influenza DNA vaccines on Thursday, July 17, at the IBC Life Sciences Next Generation Vaccines conference .http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/prnews/080714/lam026.h... |